SCTBG

Sichuan Tianshu Biopharmaceutical (SCTBG) is a China-based biotechnology company focused on the research, development, and commercialization of innovative therapies for cardiovascular diseases, metabolic disorders, and inflammatory conditions. The company maintains a diverse pipeline that includes both small molecule inhibitors and large molecule biologics, with a particular emphasis on anticoagulants and diabetes treatments. SCTBG operates integrated R&D and manufacturing facilities to support its clinical programs from early-stage discovery through to commercial production. By leveraging its expertise in protein engineering and medicinal chemistry, the company aims to address significant unmet medical needs in the Chinese and global healthcare markets.